Starpharma Holdings Limited (ASX:SPL) Insider Robert Thomas Acquires 200,000 Shares of Stock

Starpharma Holdings Limited (ASX:SPL) insider Robert Thomas acquired 200,000 shares of the company’s stock in a transaction dated Wednesday, October 23rd. The stock was purchased at an average cost of A$0.09 ($0.06) per share, with a total value of A$18,600.00 ($12,236.84).

Starpharma Price Performance

The company has a quick ratio of 5.65, a current ratio of 4.94 and a debt-to-equity ratio of 12.55.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.